Literature DB >> 10678068

[Prognosis prediction of S-phase fraction and p53, c-erbB-2, estrogen receptor, progesterone receptor in axillary node-negative breast cancer].

S Zhang1, Y Yuan, X Wang.   

Abstract

The prognostic factors in 180 axillary node-negative breast cancer patients with more than 5 year follow-up were searched for with multiple regression. Based on the regression results, the cases with treatment failure in 5 year and the cases with 5 year disease free survival were matched at 1:2 ratio. Then the c-erbB-2 protein, p53 Protein, estrogen receptor (ER), progesterone receptor (PR) and the S-phase fraction (SPF) were measured in paraffin-embedded breast cancer tissue. The results were analysed with log-rank test and Cox-Model. Among the biobehaviour factors measured, the SPF was the strongest prognosis predictor for ANN. The 5 year disease free survival rate of ANN with SPF < 10% or > 10% was 94% and 52% respectively (P < 0.001). The treatment failure relative risk of patients with SPF > 10% ANN was 11.31. The relative risk of other four factors was respectively, PR 3.58 (P < 0.002), ER 2.93 (P < 0.05), p53 1.44 (P > 0.3), c-erbB-2 1.38 (P > 0.5). The combination of PR or EP with SPF could make the relative risk even higher.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10678068

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  3 in total

1.  Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

Authors:  A Elzagheid; T Kuopio; S Pyrhönen; Y Collan
Journal:  Diagn Pathol       Date:  2006-11-08       Impact factor: 2.644

2.  Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya.

Authors:  Eramah Ermiah; Abdelbaset Buhmeida; Fathi Abdalla; Ben Romdhane Khaled; Nada Salem; Seppo Pyrhönen; Yrjö Collan
Journal:  J Cancer       Date:  2012-10-01       Impact factor: 4.207

3.  Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues.

Authors:  Chao Shen; Meijia Gu; Dan Liang; Lixia Miao; Liu Hu; Congyi Zheng; Jiakuan Chen
Journal:  Cancer Cell Int       Date:  2009-01-02       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.